Search

Your search keyword '"Tonini G."' showing total 125 results

Search Constraints

Start Over You searched for: Author "Tonini G." Remove constraint Author: "Tonini G." Topic business.industry Remove constraint Topic: business.industry
125 results on '"Tonini G."'

Search Results

1. Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia

2. Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study

3. Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

4. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

5. Prevalence of malnutrition in patients at first medical oncology visit: The PreMiO study

6. The bone anabolic therapy

7. Final Height of Patients with Turner’s Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy

8. The NuGO proof of principle study package: a collaborative research effort of the European Nutrigenomics Organisation

9. Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

10. Breast cancer 'tailored follow-up' in Italian oncology units: a web-based survey

11. Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial

12. Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

13. Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: Evidence from a nationwide Italian twin study

14. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study

15. Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study

16. Usefulness of three ECG analysis methods in evaluation of ventricular ectopic activity of asymptomatic sportsmen

17. Liver Toxicity in Colorectal Cancer Patients Treated with First Line Folfiri-Containing Regimen: a Single Institution Experience

18. Second-line treatment in exon 11-mutated GIST patients: Imatinib dose escalation or sunitinib? Retrospective analysis of a multi-institutional experience

19. Optimal therapy of pubertal disorders in precocious/early puberty

20. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

21. The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial

22. Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

23. Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016

24. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

25. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

26. Early integration of palliative care in oncology practice: Results of the Italian Association of Medical Oncology (AIOM) survey

27. Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA

28. Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study

29. Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study

30. Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer

31. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study

32. Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients

33. Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)

34. Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

35. PML down-regulation in soft tissue sarcomas

36. Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial

37. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

38. PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

39. S-Adenosylmethionine Supplementation May Reduce Cancer-Related Fatigue: A Prospective Evaluation Using the FACIT-F Questionnaire in Colon Cancer Patients Undergoing Oxaliplatin-Based Chemotherapy Regimens

40. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

41. Recent Advances in Desmoid Tumor Therapy

42. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

43. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

44. Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

45. Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: Results from an international, multi-institutional, retrospective analysis

46. Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin

47. Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis

48. EAGLES study: First-line Bevacizumab in Combination with Chemotherapy in Elderly Patients with Advanced, Metastatic, Non-squamous Non-small Cell Lung Cancer

49. How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials

50. Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors

Catalog

Books, media, physical & digital resources